Peak monthly Google Ads revenue, reached in month five
ROAS at peak, scaled up from below breakeven in month one
The peptides space is one of the most difficult product categories to advertise on Google. The products sit in a regulatory gray area, not outright banned, but constantly flagged. Headlines get disapproved. Product listings get pulled. Descriptions trigger policy violations. Running a clean, compliant account in this niche requires constant attention, fast reactions, and a team that understands where the lines sit.
When this US-based peptides brand came to us, they had a working store: a WooCommerce site with some organic traffic, US-manufactured product, card payment processing already in place, and a calm, professional team behind it. What they did not have was any real acquisition engine. There was no structured Google Ads account, no email marketing, no retention system, and no list, flows, or campaigns of any kind. Every channel that could drive growth beyond organic search was empty.
The opportunity was there. The peptide market is worth $50B+ and growing at 7%+ CAGR, but it is also one of the hardest niches to market online. That combination, real demand and heavy compliance friction, meant the brand needed a team that could operate right up to the edge of what Google allows without getting the account shut down.
Before Budai Media
After Budai Media (Month 5 peak)
1. Starting From Zero, On Purpose
November 2025 was month one. There was no existing account structure worth salvaging, so we built from the ground up. That first month was deliberately slow: $7,000 in spend generated $4,500 in revenue, a ROAS below 1.0.
That is expected when a Google Ads account is starting from nothing in a restricted category. The approach was to budget 30 to 60 days for the algorithm to learn, feeding it data through a spread of audiences, search terms, and products, rather than panicking and cutting the budget the moment the numbers looked weak.
The screenshot below shows that first month, November 1 to 30, 2025, with the account tracking $4,534 in conversion value against $7,615 in cost:
2. Scaling With Discipline
Once the account found its footing, spend increased only when performance justified it. The scaling tactic throughout was steady: 10 to 15% daily budget increases, never a sudden jump big enough to shock the algorithm back into a fresh learning phase.
The chart below shows the five-month revenue progression across the scaling period, from $4,500 in month one to $505,000 by month five:
By month five, the account was generating $505K in monthly revenue on roughly $210K in ad spend, a 2-2.5x ROAS. That is the number we point to as the peak of the scaling period.
3. A Window Into the Account Mid-Scale
Performance across any single 30-day window will look different from the account’s overall trajectory, and it’s worth showing that alongside the headline numbers rather than only the best month. The screenshot below is a real 30-day snapshot from February 12 to March 13, 2026, sitting inside the broader scaling period: $311,293 in conversion value against $150,144 in cost, a return of roughly 2.1x over that specific window, alongside 2.76M impressions and 1,481 conversions.
4. Managing Compliance in a Restricted Category
Advertising peptides on Google is not a set-and-forget operation. Disapprovals on headlines, descriptions, and product listings are common. Merchant Center suspensions happen. Payment processors have their own rules to satisfy, and Google’s own policies shift on a near-weekly basis.
We manage that by watching 16 RUO peptide accounts every week to track what is and is not getting approved across the category, which keeps roughly 70-80% of this brand’s products in approved status at any given time. On top of that, we maintain ongoing site hygiene, correct Research Use Only labeling and certificates of analysis, and keep a standing Merchant Center recovery plan ready for when a suspension does hit.
5. Extending the Engine Beyond Google Ads
Google Ads has been the primary focus and the main growth driver, but it has not been the only channel in motion. An email retention system was also built out (and rebuilt after a mid-scale platform ban forced a two-week migration), and Meta Ads were layered in later, reaching roughly $135K in monthly revenue at a 25x ROAS. Both support the picture, but Google Ads remains the story this case study is built around.
From November 2025 to March 2026, this peptide brand went from a Google Ads account with no structure and no real revenue to one generating $505K in a single month.
1. A losing month one is often the price of admission, not a failure signal. Month one’s ROAS below 1.0 looked bad in isolation. It was the cost of building an account that could later run at 2-2.5x.
2. Restricted categories reward operators who specialize in them. Peptides advertising is difficult enough that most agencies will not touch it. The constant compliance management, disapprovals, rewrites, and recoveries, is work that requires experience and patience.
3. Scale deliberately. 10-15% daily budget increases preserve the algorithm’s learning. Larger jumps risk resetting it and losing the progress already built.
4. Compliance monitoring has to be a standing weekly process. Watching 16 RUO accounts every week, not a one-time fix, is what keeps a 70-80% product approval rate possible in a category where policy shifts constantly.
5. Once Google Ads works, it becomes the anchor, not the whole story. The channel earned its own focus here, but the strongest accounts in this niche end up supported by retention and other paid channels alongside it.
Five months. One Google Ads account that started with no structure and a ROAS under 1.0, in one of the most compliance-heavy advertising categories on the platform. By month five, it was generating $505K in a single month on roughly $210K in spend, a 2-2.5x return.
None of that happened by accident. It came from a deliberate build: a slow, data-gathering first month, disciplined 10-15% scaling from there, and constant, weekly compliance management to keep the account in good standing while it grew.
Momentum has continued since. Google Ads is now generating $450K+ a month for this brand, as part of $600K+ in total monthly store revenue across all channels.
Ready to take your peptide brand to the next level with a team that understands the industry?
